论文部分内容阅读
本文研究酶联免疫吸附试验(ELISA)检测特异性IgG、IgM和IgE在日本血吸虫病诊断和疗效考核中的意义。发现在207例确诊的血吸虫病患者中,ELISA的阳性率为97.6％,65例非血吸虫病患者无1例呈假阳性反应。吡喹酮治疗后6～8个月随访,在117倒粪检阴转者中,ELISA-IgM的阴转率为80.3％。就这点而论,血吸虫病化疗后IgM阴性值可能意味着有效治疗。50例同时进行微量采血法和静脉采血法,其中48例的结果相符,可以说明微量采血法是现场试验选用的一种方法。
In this paper, enzyme-linked immunosorbent assay (ELISA) detection of specific IgG, IgM and IgE in the diagnosis of schistosomiasis Japan and the significance of the assessment. It was found in 207 cases of schistosomiasis patients confirmed that the ELISA positive rate was 97.6%, 65 cases of non-schistosomiasis patients showed no false positive reaction. Praziquantel treatment 6-8 months follow-up, 117 inverted fecal seizure negative, ELISA-IgM negative conversion rate was 80.3%. In this regard, the negative IgM value of schistosomiasis after chemotherapy may mean effective treatment. 50 cases of simultaneous micro-blood collection and venous blood collection method, of which 48 cases of the results match, we can see that micro-blood collection method is a field test method used.